Atrium Therapeutics, Inc. (RNA) stock
RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.64+0.16 (+2.47%)
Close on Nov 18, 2026Market cap $113.58MP/E –Yield –
Atrium Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -27.8% | +306.9 |
| Q2 FY2026 | Jun 30, 2026 | -672.0% | −198.4 |
| Q1 FY2026 | Mar 31, 2026 | -84.7% | – |
| Q3 FY2025 | Sep 30, 2025 | -0.3% | – |
| Q2 FY2025 | Jun 30, 2025 | -334.8% | – |
| Q1 FY2025 | Mar 31, 2025 | -473.6% | – |
See a number that looks wrong?